RESUMEN
OBJECTIVE: To contribute to the recognition of psychotherapeutic nursing (PTN) as a regulated advanced clinical practice (ACP) in Spain, as is the case in other countries. BACKGROUND: Nurses are continually evolving to improve overall health outcomes. PTN has become a reality, with several authors describing it as an ACP. In Spain, psychotherapy is not officially regulated, which has led to a significant number of psychiatric nurses adopting an important ACP in this area without recognition. SOURCES OF EVIDENCE: Evidence confirms that PTN possesses the attributes necessary to be considered an ACP. Nurses, like psychotherapists, independently address the complex needs of individuals and families within the context of therapeutic relationships, and there is a pressing need to advance formal processes of regulation and certification. DISCUSSION: PTN has evolved at different rates depending on local initiatives, policies and various professional interests. In Spain, it is crucial to evaluate its outcomes, recognise it as an ACP and develop training plans for its regulation and accreditation. CONCLUSIONS: Mental health nurses in Spain have a strong interest in PTN being recognised as an ACP. To this end, they should join forces with other partners, scientific associations and international bodies such as the International Council of Nurses (ICN) to make PTN an internationally recognised ACP. IMPLICATIONS FOR NURSING PRACTICE: Psychotherapeutic nurses could contribute to improving mental health outcomes, client satisfaction and health system efficiency, and their formal recognition is an opportunity to enhance their professional identity, competence and autonomy. IMPLICATIONS FOR NURSING POLICY: Nursing policy needs to be reoriented towards strengthening psychotherapy as an ACP. Synergies and alliances between international nursing associations and the ICN can promote its development and implementation, while research, education and leadership are essential to achieving official regulation and accreditation.
Asunto(s)
Enfermería Psiquiátrica , Psicoterapia , Humanos , España , Enfermería de Práctica Avanzada , Rol de la Enfermera , Promoción de la Salud , Trastornos Mentales/enfermería , Trastornos Mentales/terapia , Servicios de Salud Mental/organización & administración , Salud MentalRESUMEN
BACKGROUND: Liquid biopsy and Integrative Genomic Profiling (IGP) are yet to be implemented into routine Radiation Oncology. Here we assess the utility of germline, tumour and circulating cell-free DNA-based genomic analyses for the clinical management of early-stage and oligometastatic cancer patients treated by precision radiotherapy. METHODS: We performed germline, tissue- and liquid biopsy NGS panels on 50 early-stage/oligometastatic cancer patients undergoing radiotherapy. We also monitored ctDNA variants in serial liquid biopsies collected during radiotherapy and follow-up and evaluated the clinical utility of such comprehensive approach. RESULTS: The integration of different genomic studies revealed that only 1/3 of the liquid biopsy variants are of tumour origin. Altogether, 55 tumour variants (affecting 3/4 of the patients) were considered potentially actionable (for treatment and prognosis), whereas potential follow-up biomarkers were identified in all cases. Germline cancer-predisposing variants were present in three patients, which would have not been eligible for hereditary cancer testing according to clinical guidelines. The presence of detectable ctDNA variants before radiotherapy was associated with progression-free survival both in oligometastatic patients and in those with early-stage. CONCLUSIONS: IGP provides both valuable and actionable information for personalised decision-making in Radiation Oncology.
Asunto(s)
ADN Tumoral Circulante , Neoplasias , Oncología por Radiación , Humanos , ADN Tumoral Circulante/genética , Biomarcadores de Tumor/genética , Biopsia Líquida , Genómica , MutaciónRESUMEN
OBJECTIVE: The biallelic inheritance of an expanded intronic pentamer (AAGGG)exp in the gene encoding replication factor C subunit 1 (RFC1) has been found to be a cause of cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS). This study describes clinical and genetic features of our patients with clinical suspicion of the syndrome. STUDY DESIGN: A retrospective descriptive study from an ataxia database comprising 500 patients. SETTING: The study was performed at the Otorhinolaryngology Department of a hospital in the north of Spain. METHODS: Specific genetic testing for CANVAS was performed in 13 patients with clinical suspicion of complete or incomplete syndrome. The clinical diagnosis was supported by quantitative vestibular hypofunction, cerebellar atrophy, and abnormal sensory nerve conduction testing. RESULTS: Nine of 13 (69%) patients met clinical diagnostic criteria for definite CANVAS disease. The first manifestation of the syndrome was lower limb dysesthesia in 8 of 13 patients and gait imbalance in 5 of 13. Eleven of 13 (85%) patients were carriers of the biallelic (AAGGG)exp in RFC1. CONCLUSION: A genetic cause of CANVAS has recently been discovered. We propose genetic screening for biallelic expansions of the AAGGG pentamer of RFC1 in all patients with clinical suspicion of CANVAS, since accurate early diagnosis could improve the quality of life of these patients.
Asunto(s)
Vestibulopatía Bilateral/diagnóstico , Vestibulopatía Bilateral/genética , Ataxia Cerebelosa/diagnóstico , Ataxia Cerebelosa/genética , Expansión de las Repeticiones de ADN/genética , Proteína de Replicación C/genética , Anciano , Bases de Datos Factuales , Diagnóstico Diferencial , Femenino , Pruebas Genéticas , Humanos , Intrones/genética , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , España , Evaluación de Síntomas , SíndromeRESUMEN
Intestinal-type sinonasal adenocarcinoma (ITAC) is a rare tumor carrying poor prognosis and needing new treatment options. The aim of this study was to identify actionable gene mutations that can guide new personalized target-specific therapies in ITAC patients. A series of 48 tumor and 27 corresponding germline DNA samples were analyzed by next generation sequencing using a panel of 120 genes. In total, 223 sequence variants were found in 70 genes. Matched tumor/germline comparison in 27 cases revealed that 57% were in fact germline variants. In 20 of these 27 cases, 58 somatic variants in 33 different genes were identified, the most frequent being PIK3CA (5 cases), APC and ATM (4 cases), and KRAS, NF1, LRP1B and BRCA1 (3 cases). Many of the somatic gene variants affected PI3K, MAPK/ERK, WNT and DNA repair signaling pathways, although not in a mutually exclusive manner. None of the alterations were related to histological ITAC subtype, tumor stage or survival. Our data showed that thorough interpretation of somatic mutations requires sequencing analysis of the corresponding germline DNA. Potentially actionable somatic mutations were found in 20 of 27 cases, 8 of which being biomarkers of FDA-approved targeted therapies. Our data implicate new possibilities for personalized treatment of ITAC patients.
Asunto(s)
Adenocarcinoma/genética , Biomarcadores de Tumor/genética , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Fosfatidilinositol 3-Quinasa Clase I/genética , Reparación del ADN/genética , Reparación del ADN/fisiología , Genes BRCA1/fisiología , Humanos , Mutación/genética , Proteínas Proto-Oncogénicas p21(ras)/genética , Receptores de LDL/genéticaRESUMEN
The stereocilia of the inner ear sensory cells contain the actin-binding protein radixin, encoded by RDX. Radixin is important for hearing but remains functionally obscure. To determine how radixin influences hearing sensitivity, we used a custom rapid imaging technique to visualize stereocilia motion while measuring electrical potential amplitudes during acoustic stimulation. Radixin inhibition decreased sound-evoked electrical potentials. Other functional measures, including electrically induced sensory cell motility and sound-evoked stereocilia deflections, showed a minor amplitude increase. These unique functional alterations demonstrate radixin as necessary for conversion of sound into electrical signals at acoustic rates. We identified patients with RDX variants with normal hearing at birth who showed rapidly deteriorating hearing during the first months of life. This may be overlooked by newborn hearing screening and explained by multiple disturbances in postnatal sensory cells. We conclude radixin is necessary for ensuring normal conversion of sound to electrical signals in the inner ear.
Asunto(s)
Proteínas del Citoesqueleto/metabolismo , Células Ciliadas Auditivas Externas/metabolismo , Proteínas de la Membrana/metabolismo , Estereocilios/metabolismo , Estimulación Acústica , Alelos , Animales , Arsenicales/farmacología , Preescolar , Proteínas del Citoesqueleto/genética , Modelos Animales de Enfermedad , Femenino , Técnica del Anticuerpo Fluorescente , Expresión Génica , Variación Genética , Genotipo , Cobayas , Células Ciliadas Auditivas Externas/efectos de los fármacos , Pérdida Auditiva/diagnóstico , Pérdida Auditiva/genética , Humanos , Mecanotransducción Celular/genética , Proteínas de la Membrana/genética , Modelos Biológicos , Linaje , Estereocilios/efectos de los fármacosRESUMEN
PURPOSE: In the era of precision medicine, genomic characterization of blind patients is critical. Here, we evaluate the effects of comprehensive genetic analysis on the etiologic diagnosis of potentially hereditary vision loss and its impact on clinical management. METHODS: We studied 100 non-syndromic and syndromic Spanish patients with a clinical diagnosis of blindness caused by alterations on the retina, choroid, vitreous and/or optic nerve. We used a next-generation sequencing (NGS) panel (OFTALMOgenics™), developed and validated within this study, including up to 362 genes previously associated with these conditions. RESULTS: We identified the genetic cause of blindness in 45% of patients (45/100). A total of 28.9% of genetically diagnosed cases (13/45) were syndromic and, of those, in 30.8% (4/13) extraophthalmic features had been overlooked and/or not related to visual impairment before genetic testing, including cases with Mainzer-Saldino, Bardet-Biedl, mucolipidosis and MLCRD syndromes. In two additional cases-syndromic blindness had been proposed before, but not specifically diagnosed, and one patient with Heimler syndrome had been misdiagnosed as an Usher case before testing. 33.3% of the genetically diagnosed patients (15/45) had causative variants in genes targeted by clinical trials exploring the curative potential of gene therapy approaches. CONCLUSION: Comprehensive genomic testing provided clinically relevant insights in a large proportion of blind patients, identifying potential therapeutic opportunities or previously undiagnosed syndromes in 42.2% of the genetically diagnosed cases (19/45).
Asunto(s)
Manejo de la Enfermedad , Pruebas Genéticas/métodos , Genómica/métodos , Enfermedades del Nervio Óptico/genética , Enfermedades de la Retina/genética , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Enfermedades del Nervio Óptico/diagnóstico , Enfermedades del Nervio Óptico/terapia , Linaje , Fenotipo , Enfermedades de la Retina/diagnóstico , Enfermedades de la Retina/terapia , SíndromeRESUMEN
INTRODUCTION: Sensorineural hearing loss (SNL) is the most prevalent sensory deficit in our environment. Next generation genomic sequencing (NGS) enables an aetiological diagnosis in a high percentage of patients. Our pilot study shows the results of the systematic application of NGS in a Childhood Hearing Loss Unit, as well as its implications for the clinical management of patients and their families. MATERIAL AND METHOD: We included 27 patients diagnosed with SNL between 2014 and 2017, in which an environmental cause was ruled out. The genetic test consisted of a panel of genes analyzed by NGS (OTOgenicsTM panel). This panel has been designed to include genes associated with sensorineural or mixed hearing loss, early onset or late, syndromic and non-syndromic, regardless of their inheritance pattern. RESULTS: A genetic diagnosis was obtained in 56% (15/27) of the patients (62% in the case of bilateral SNL). Of the patients, 5/27 (19%) presented pathogenic variants in the GJB2 gene and the rest pathogenic and / or probably pathogenic variants in other genes associated with isolated SNL (PR2X2, TECTA and STRC), with syndromic SNL (CHD7, GATA3, COL4A5, MITF and SOX10) or with syndromic and non-syndromic SNL (BSND, ACTG1 and CDH23). DISCUSSION: The aetiological diagnosis of SNL is a challenge in clinical practice. Our series demonstrates that it is possible to implement genetic diagnosis in the care routine and that this information has prognostic and therapeutic implications.
Asunto(s)
Pérdida Auditiva Sensorineural/genética , Secuenciación de Nucleótidos de Alto Rendimiento , Análisis de Secuencia de ADN , Niño , Preescolar , Pérdida Auditiva Sensorineural/diagnóstico , Humanos , Lactante , Proyectos PilotoRESUMEN
PURPOSE: Amplifications of receptor tyrosine kinases (RTKS) are therapeutic targets in multiple tumor types (e.g. HER2 in breast cancer), and amplification of the chromosome 4 segment harboring the three RTKs KIT, PDGFRA, and KDR (4q12amp) may be similarly targetable. The presence of 4q12amp has been sporadically reported in small tumor specific series but a large-scale analysis is lacking. We assess the pan-cancer landscape of 4q12amp and provide early clinical support for the feasibility of targeting this amplicon. EXPERIMENTAL DESIGN: Tumor specimens from 132,872 patients with advanced cancer were assayed with hybrid capture based comprehensive genomic profiling which assays 186-315 genes for all classes of genomic alterations, including amplifications. Baseline demographic data were abstracted, and presence of 4q12amp was defined as 6 or more copies of KIT/KDR/PDGFRA. Concurrent alterations and treatment outcomes with matched therapies were explored in a subset of cases. RESULTS: Overall 0.65% of cases harbored 4q12amp at a median copy number of 10 (range 6-344). Among cancers with >100 cases in this series, glioblastomas, angiosarcomas, and osteosarcomas were enriched for 4q12amp at 4.7%, 4.8%, and 6.4%, respectively (all p < 0.001), giving an overall sarcoma (n = 6,885) incidence of 1.9%. Among 99 pulmonary adenocarcinoma cases harboring 4q12amp, 50 (50%) lacked any other known driver of NSLCC. Four index cases plus a previously reported case on treatment with empirical TKIs monotherapy had stable disease on average exceeding 20 months. CONCLUSION: We define 4q12amp as a significant event across the pan-cancer landscape, comparable to known pan-cancer targets such as NTRK and microsatellite instability, with notable enrichment in several cancers such as osteosarcoma where standard treatment is limited. The responses to available TKIs observed in index cases strongly suggest 4q12amp is a druggable oncogenic target across cancers that warrants a focused drug development strategy. IMPLICATIONS FOR PRACTICE: Coamplification of the receptor tyrosine kinases (rtks) KIT/KDR/PDGFRA (4q12amp) is present broadly across cancers (0.65%), with enrichment in osteosarcoma and gliomas. Evidence for this amplicon having an oncogenic role is the mutual exclusivity of 4q12amp to other known drivers in 50% of pulmonary adenocarcinoma cases. Furthermore, preliminary clinical evidence for driver status comes from four index cases of patients empirically treated with commercially available tyrosine kinase inhibitors with activity against KIT/KDR/PDGFRA who had stable disease for 20 months on average. The sum of these lines of evidence suggests further clinical and preclinical investigation of 4q12amp is warranted as the possible basis for a pan-cancer drug development strategy.
Asunto(s)
Amplificación de Genes/genética , Neoplasias/genética , Proteínas Tirosina Quinasas Receptoras/genética , Receptor alfa de Factor de Crecimiento Derivado de Plaquetas/metabolismo , Receptor 2 de Factores de Crecimiento Endotelial Vascular/genética , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Humanos , Persona de Mediana Edad , Adulto JovenRESUMEN
Abstract The present study investigated the effect of eccentric overload on professional basketball players. Participants were 8 players aged 18-25 years who play in a Leb Oro League team. There was an 8 week training cycle with 1 weekly session of half squats. The control group performed training following a traditional methodology -using free weights- whereas the experimental group used inertial technology, that is, the ProSquat machine from Proinertial®. Both vertical jump and 30-meter sprint were assessed before and after intervention. The following conclusions were reached: a) strength training with vertical vector improves the 30-meter sprint test and also the vertical jump; b) training program that affects the eccentric overload of the movement results in more improvements than traditional training with the same duration; c) training in the vertical vector also has an impact on the way force is manifested in the horizontal vector, showing improvements in the 30-meter sprint.
Resumo O presente estudo investigou o efeito da sobrecarga excêntrica em jogadores profissionais de basquetebol. Os participantes foram 8 jogadores de uma equipe da Leb Gold League entre 18 e 25 anos. Um ciclo de treinamento de 8 semanas foi realizado com 1 sessão semanal no exercício de meio agachamento. O grupo controle realizou o treinamento com metodologia tradicional, com pesos livres, e o grupo experimental, por meio de tecnologia inercial, com a máquina ProSquat, Proinertial®. O salto vertical e o sprint de 30 metros foram avaliados antes e após a intervenção. As seguintes conclusões foram obtidas: a) o treinamento de força com um componente no vetor vertical mostra melhorias no teste de 30 metros e no salto vertical; b) um programa que afeta a sobrecarga de movimento excêntrico apresenta resultados com melhores desempenhos do que o treinamento tradicional; c) o treinamento no vetor vertical também afeta uma expressão da força no vetor horizontal, mostrando melhorias no sprint de 30 metros.
RESUMEN
INTRODUCTION AND OBJECTIVES: Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease. The current challenge relies on the accurate classification of the pathogenicity of the variants. Transthoracic echocardiography (TTE) is recommended at initial evaluation and cardiac magnetic resonance (CMR) imaging should also be considered. We aimed to reappraise the penetrance and clinical expression of the MYBPC3 p.G263* variant. METHODS: Three hundred and eighty-four HCM probands and a control cohort of 450 individuals were studied for the main sarcomere genes by next-generation sequencing. All MYBPC3 p.G263* carriers were identified and family screening was performed. Clinical information was recorded retrospectively before 2015 and prospectively thereafter. Extra effort was invested in performing CMR in all carriers, despite TTE results. RESULTS: Thirteen HCM probands and none of the controls were carriers of the MYBPC3 p.G263* pathogenic variant (according to the American College of Medical Genetics and Genomics and the Association for Molecular Pathology). A total of 39 carriers were identified with family screening. Most patients with HCM were asymptomatic at the time of diagnosis and showed late-onset disease. Despite having a relatively benign course in the young, late HCM-related complications could occur. Penetrance was around 70% when evaluated by TTE and was 87.2% with TTE plus CMR. Penetrance was age-dependent, reaching 100% in carriers older than 55 years. CONCLUSIONS: MYBPC3 p.G263* shares with most truncating pathogenic variants in this gene a late onset, relatively benign clinical course in the young, and high penetrance. Cardiac magnetic resonance could be a useful tool to evaluate carriers despite TTE results.
Asunto(s)
Cardiomiopatía Hipertrófica Familiar/genética , Proteínas Portadoras/genética , Efecto Fundador , Anciano , Anciano de 80 o más Años , Cardiomiopatía Hipertrófica Familiar/diagnóstico , Estudios de Casos y Controles , Ecocardiografía , Femenino , Heterocigoto , Humanos , Angiografía por Resonancia Magnética , Masculino , Persona de Mediana Edad , Linaje , Estudios Prospectivos , Estudios RetrospectivosRESUMEN
CONTEXTO: La cultura cada vez más coercitiva en la atención a la salud mental se pone de manifiesto en multitud de intervenciones. Es preciso tomar en consideración las aportaciones de los profesionales de salud mental como procedimiento de evaluación y determinación de factores estratégicos en la facilitación hacia un cambio de paradigma. OBJETIVO: Analizar el discurso grupal en base a las opiniones, experiencias y percepciones de las enfermeras sobre la coerción y sus límites con los valores profesionales en el ámbito de los cuidados en salud mental. MÉTODO: Estudio descriptivo de enfoque cualitativo, donde participaron once enfermeras involucradas en el proceso formativo/docente de la especialidad de enfermería de salud mental. La recolección de datos se produjo a través de la técnica de grupo focal y el contenido textual ha sido sometido al análisis temático. RESULTADOS: Las categorías temáticas identificadas son: Coerción: contexto de descubrimiento y contexto de justificación, Cuidado humano, vulnerabilidad y coerción en salud mental y Fortalezas y debilidades del cuidado profesional. CONCLUSIÓN: Los valores y actitudes emergentes de las enfermeras especialistas en salud mental se articulan en la relación de ayuda, siendo la propia identidad enfermera el resultado de esa práctica y teniendo como principal característica la gestión integral del cuidado. Los cuidados enfermeros contribuyen a la consecución práctica de los derechos humanos. El cuidado contractual supone la negación de hacerse partícipe de prácticas obligatorias o coercitivas, tratándose de incorporar en una lógica de derecho la complejidad del cuidado.
CONTEXTO: A cultura cada vez mais coercitiva da atenção em saúde mental é evidente em diversas intervenções. É preciso ter em consideração as contribuições dos profissionais da saúde mental como procedimento de avaliação e determinação de fatores estratégicos na facilitação da mudança de paradigma. OBJETIVO: Analisar o discurso grupal com base nas opiniões, experiências e percepções das enfermeiras sobre a coerção e os seus limites com os valores profissionais no âmbito dos cuidados em saúde mental. MÉTODOS: Estudo descritivo com uma abordagem qualitativa, onde participaram onze enfermeiras envolvidas no processo de formação e a docência da especialidade de enfermagem de saúde mental. A colheita de dados foi realizada através da técnica de grupo focal e o conteúdo textual foi submetido à análise temática. RESULTADOS: As categorias temáticas identificadas são: Coerção: contexto de descoberta e contexto de justificação, Do cuidado humano, vulnerabilidade e coerção em saúde mental e Fortalezas e debilidades do cuidado profissional. CONCLUSÃO: Os valores e atitudes emergentes das enfermeiras especialistas em saúde mental dependem da relação de ajuda, sendo a própria identidade da enfermeira o resultado dessa prática e tendo como principal característica a gestão integral do cuidado. Os cuidados de enfermagem contribuem à consecução prática dos direitos humanos. O cuidado contratual supõe a negação de fazer-se participante de práticas obrigatórias ou coercitivas, tratando-se de incorporar em uma lógica de direito a complexidade do cuidado.
BACKGROUND: Increasingly coercive culture in mental health care clearly comes out in a multitude of interventions. It is necessary to take into consideration the contributions of mental health professionals to evaluate and determine strategic factors to facilitate a paradigm shift. AIM: Analysis of group discourse based on the opinions, experiences and perceptions of nurses about coercion and its limits, with professional values in the field of mental health care. METHODS: Descriptive study from a qualitative approach with the participation of eleven nurses involved in the teaching- learning process about specialises in mental health. Data collection was done through the focus group technique and textual content has been subjected to thematic analysis. RESULTS: The thematic categories identified are: "Coercion: context of discovery and context of justification", "Human care, vulnerability and coercion in mental health" and "Strengths and weaknesses of professional care". CONCLUSION: Values and emerging attitudes of nurses specialized in mental health are based on aid relationships. The own nurse identity is the result of this practice and the integral management of care is the main feature. Nursing care contributes to the practical achievement of human rights. Contractual care implies the refusal to participate in compulsory or coercive practices, trying to understand the complexity of care under a logic of law.
RESUMEN
BACKGROUND: Sensorineural hearing loss (SNHL) is the most common sensory impairment. Comprehensive next-generation sequencing (NGS) has become the standard for the etiological diagnosis of early-onset SNHL. However, accurate selection of target genomic regions (gene panel/exome/genome), analytical performance and variant interpretation remain relevant difficulties for its clinical implementation. METHODS: We developed a novel NGS panel with 199 genes associated with non-syndromic and/or syndromic SNHL. We evaluated the analytical sensitivity and specificity of the panel on 1624 known single nucleotide variants (SNVs) and indels on a mixture of genomic DNA from 10 previously characterized lymphoblastoid cell lines, and analyzed 50 Spanish patients with presumed hereditary SNHL not caused by GJB2/GJB6, OTOF nor MT-RNR1 mutations. RESULTS: The analytical sensitivity of the test to detect SNVs and indels on the DNA mixture from the cell lines was > 99.5%, with a specificity > 99.9%. The diagnostic yield on the SNHL patients was 42% (21/50): 47.6% (10/21) with autosomal recessive inheritance pattern (BSND, CDH23, MYO15A, STRC [n = 2], USH2A [n = 3], RDX, SLC26A4); 38.1% (8/21) autosomal dominant (ACTG1 [n = 3; 2 de novo], CHD7, GATA3 [de novo], MITF, P2RX2, SOX10), and 14.3% (3/21) X-linked (COL4A5 [de novo], POU3F4, PRPS1). 46.9% of causative variants (15/32) were not in the databases. 28.6% of genetically diagnosed cases (6/21) had previously undetected syndromes (Barakat, Usher type 2A [n = 3] and Waardenburg [n = 2]). 19% of genetic diagnoses (4/21) were attributable to large deletions/duplications (STRC deletion [n = 2]; partial CDH23 duplication; RDX exon 2 deletion). CONCLUSIONS: In the era of precision medicine, obtaining an etiologic diagnosis of SNHL is imperative. Here, we contribute to show that, with the right methodology, NGS can be transferred to the clinical practice, boosting the yield of SNHL genetic diagnosis to 50-60% (including GJB2/GJB6 alterations), improving diagnostic/prognostic accuracy, refining genetic and reproductive counseling and revealing clinically relevant undiagnosed syndromes.
Asunto(s)
Genómica , Pérdida Auditiva/diagnóstico , Pérdida Auditiva/genética , Adolescente , Adulto , Niño , Preescolar , Femenino , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Mutación INDEL , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Fenotipo , España , Adulto JovenRESUMEN
BACKGROUND: Next-generation sequencing (NGS) opens new options in clinical oncology, from therapy selection to genetic counseling. However, realization of this potential not only requires succeeding in the bioinformatics and interpretation of the results, but also in their integration into the clinical practice. We have developed a novel NGS diagnostic platform aimed at detecting (1) somatic genomic alterations associated with the response to approved targeted cancer therapies and (2) germline mutations predisposing to hereditary malignancies. METHODS: Next-generation sequencing libraries enriched in the exons of 215 cancer genes (97 for therapy selection and 148 for predisposition, with 30 informative for both applications), as well as selected introns from 17 genes involved in drug-related rearrangements, were prepared from 39 tumors (paraffin-embedded tissues/cytologies), 36 germline samples (blood) and 10 cell lines using hybrid capture. Analysis of NGS results was performed with specifically developed bioinformatics pipelines. RESULTS: The platform detects single-nucleotide variants (SNVs) and insertions/deletions (indels) with sensitivity and specificity >99.5% (allelic frequency ≥0.1), as well as copy-number variants (CNVs) and rearrangements. Somatic testing identified tailored approved targeted drugs in 35/39 tumors (89.74%), showing a diagnostic yield comparable to that of leading commercial platforms. A somatic EGFR p.E746_S752delinsA mutation in a mediastinal metastasis from a breast cancer prompted its anatomopathologic reassessment, its definite reclassification as a lung cancer and its treatment with gefitinib (partial response sustained for 15 months). Testing of 36 germline samples identified two pathogenic mutations (in CDKN2A and BRCA2). We propose a strategy for interpretation and reporting of results adaptable to the aim of the request, the availability of tumor and/or normal samples and the scope of the informed consent. CONCLUSION: With an adequate methodology, it is possible to translate to the clinical practice the latest advances in precision oncology, integrating under the same platform the identification of somatic and germline genomic alterations.
RESUMEN
The development of intensity-modulated radiotherapy (IMRT) has played a major role in improving outcomes and decreasing morbidity in patients with head and neck cancer. This review addresses this vital modality with a focus on the important role of the head and neck surgeon. The technique as well as its benefits and points of caution are outlined, the definitions of tumor and treatment volumes are discussed, and the dose and fractionation are detailed. Following this are several sections dedicated to the role of the head and neck surgeon in the planning of both definitive and postoperative radiotherapy to the primary site and neck. There is a focus throughout on anatomic and surgical considerations; commonly encountered situations are illustrated. With a deeper understanding of this technique and their own pivotal contribution to target delineation, head and neck surgeons will be poised to expand their role and improve cancer care for their patients. © 2015 Wiley Periodicals, Inc. Head Neck 38: E2368-E2373, 2016.
Asunto(s)
Neoplasias de Cabeza y Cuello/radioterapia , Radioterapia de Intensidad Modulada , Fraccionamiento de la Dosis de Radiación , Humanos , Dosificación Radioterapéutica , Planificación de la Radioterapia Asistida por Computador , CirujanosRESUMEN
Laryngeal squamous cell carcinoma is a frequent and significant cause of morbidity and mortality. Here we explore the biological basis of this aggressive tumour, and identify two cell-cell adhesion genes as recurrently mutated in this malignancy. We first perform exome sequencing of four laryngeal carcinomas and their matched normal tissues. Among the 569 genes found to present somatic mutations, and based on their recurrence or functional relevance in cancer, we select 40 for further validation in 86 additional laryngeal carcinomas. We detect frequent mutations (14 of 90, 15%) in CTNNA2 and CTNNA3-encoding α-catenins. Functional studies reveal an increase in the migration and invasive ability of head and neck squamous cell carcinoma cells producing mutated forms of CTNNA2 and CTNNA3 or in cells where both α-catenins are silenced. Analysis of the clinical relevance of these mutations demonstrates that they are associated with poor prognosis. We conclude that CTNNA2 and CTNNA3 are tumour suppressor genes frequently mutated in laryngeal carcinomas.
Asunto(s)
Biomarcadores de Tumor/genética , Carcinoma de Células Escamosas/genética , Neoplasias Laríngeas/genética , Mutación , alfa Catenina/genética , Secuencia de Aminoácidos , Biomarcadores de Tumor/química , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/patología , Adhesión Celular , Movimiento Celular , Exoma , Expresión Génica , Humanos , Neoplasias Laríngeas/diagnóstico , Neoplasias Laríngeas/patología , Modelos Moleculares , Datos de Secuencia Molecular , Invasividad Neoplásica , Pronóstico , Análisis de Secuencia de ADN , alfa Catenina/químicaRESUMEN
Defining the relationship between ageing and cancer is a crucial but challenging task. Mice deficient in Zmpste24, a metalloproteinase mutated in human progeria and involved in nuclear prelamin A maturation, recapitulate multiple features of ageing. However, their short lifespan and serious cell-intrinsic and cell-extrinsic alterations restrict the application and interpretation of carcinogenesis protocols. Here we present Zmpste24 mosaic mice that lack these limitations. Zmpste24 mosaic mice develop normally and keep similar proportions of Zmpste24-deficient (prelamin A-accumulating) and Zmpste24-proficient (mature lamin A-containing) cells throughout life, revealing that cell-extrinsic mechanisms are preeminent for progeria development. Moreover, prelamin A accumulation does not impair tumour initiation and growth, but it decreases the incidence of infiltrating oral carcinomas. Accordingly, silencing of ZMPSTE24 reduces human cancer cell invasiveness. Our results support the potential of cell-based and systemic therapies for progeria and highlight ZMPSTE24 as a new anticancer target.
Asunto(s)
Neoplasias/patología , Proteínas Nucleares/metabolismo , Progeria/metabolismo , Progeria/patología , Precursores de Proteínas/metabolismo , Envejecimiento/patología , Animales , Biomarcadores/metabolismo , Carcinogénesis/patología , Femenino , Humanos , Lamina Tipo A , Masculino , Proteínas de la Membrana/deficiencia , Proteínas de la Membrana/metabolismo , Metaloendopeptidasas/deficiencia , Metaloendopeptidasas/metabolismo , Ratones , Mosaicismo , Invasividad Neoplásica , Neoplasias/metabolismo , FenotipoRESUMEN
BACKGROUND AND AIM: The majority of mismatch repair (MMR) gene mutations causing Lynch syndrome (LS) occur either in MLH1 or MSH2. However, the relative contribution of PMS2 is less well defined. The aim of this study was to evaluate the role of PMS2 in LS by assessing the pathogenicity of variants of unknown significance (VUS) detected in the mutational analysis of PMS2 in a series of Spanish patients. METHODS: From a cohort of 202 LS suspected patients, 13 patients showing loss of PMS2 expression in tumours were screened for germline mutations in PMS2, using a long range PCR based strategy and multiplex ligation dependent probe amplification (MLPA). Pathogenicity assessment of PMS2 VUS was performed evaluating clinicopathological data, frequency in control population and in silico and in vitro analyses at the RNA and protein level. RESULTS: Overall 25 different PMS2 DNA variants were detected. Fourteen were classified as polymorphisms. Nine variants were classified as pathogenic: seven alterations based on their molecular nature and two after demonstrating a functional defect (c.538-3C>G affected mRNA processing and c.137G>T impaired MMR activity). The c.1569C>G variant was classified as likely neutral while the c.384G>A remained as a VUS. We have also shown that the polymorphic variant c.59G>A is MMR proficient. CONCLUSIONS: Pathogenic PMS2 mutations were detected in 69% of patients harbouring LS associated tumours with loss of PMS2 expression. In all, PMS2 mutations account for 6% of the LS cases identified. The comprehensive functional analysis shown here has been useful in the classification of PMS2 VUS and contributes to refining the role of PMS2 in LS.
Asunto(s)
Adenosina Trifosfatasas/genética , Neoplasias Colorrectales Hereditarias sin Poliposis/genética , Enzimas Reparadoras del ADN/genética , Proteínas de Unión al ADN/genética , Mutación de Línea Germinal , Estudios de Cohortes , Neoplasias Colorrectales Hereditarias sin Poliposis/patología , Reparación de la Incompatibilidad de ADN , Variación Genética , Células HEK293 , Humanos , Endonucleasa PMS2 de Reparación del Emparejamiento Incorrecto , Polimorfismo Genético , TransfecciónRESUMEN
BACKGROUND: The ability to identify individuals at increased risk of cancer is of immediate clinical relevance. Germline mutations in the CDKN2A locus, encoding the key tumor suppressor proteins p16/INK4A and p14/ARF, are frequently present in kindreds with hereditary cutaneous melanoma but have seldom been reported in families with genetic susceptibility to head and neck squamous cell carcinomas (HNSCC). METHODS: We report the pedigree of a patient with an unusually high incidence of HNSCC and melanomas. CDKN2A mutation analysis was performed with standard capillary sequencing and multiplex ligation-dependent probe amplification. RESULTS: A previously unreported germline CDKN2A mutation affecting only the p16/INK4A open reading frame, c.106delG (p.Ala36ArgfsX17), was detected in the proband. This mutation causes a premature termination codon. CONCLUSIONS: Our report emphasizes the need to consider germinal CDKN2A mutations in the differential diagnosis of familial HNSCC and the importance of awareness of these tumors in carriers of CDKN2A mutations.
Asunto(s)
Carcinoma de Células Escamosas/genética , Inhibidor p16 de la Quinasa Dependiente de Ciclina/genética , Mutación de Línea Germinal , Neoplasias de Cabeza y Cuello/genética , Melanoma/genética , Proteínas Supresoras de Tumor/genética , Genes p16 , Pruebas Genéticas , Humanos , Masculino , Persona de Mediana Edad , Linaje , Carcinoma de Células Escamosas de Cabeza y CuelloRESUMEN
Progeria syndromes are rare disorders that involve premature aging. Mutations in BANF1 have been recently reported to cause a new hereditary progeroid syndrome that we now propose to call the Néstor-Guillermo progeria syndrome (NGPS). We describe herein the clinical features of the first two NGPS patients, who phenocopy features of classic progerias (i.e., Hutchinson-Gilford progeria syndrome or mandibuloacral dysplasia), such as aged appearance, growth retardation, decreased subcutaneous fat, thin limbs, and stiff joints. However, these NGPS patients have a distinctive phenotype. In their early adulthood (32 and 24 years of age), they have no signs of cardiovascular impairment, diabetes mellitus, or hypertriglyceridemia. In contrast, they suffer profound skeletal abnormalities that affect their quality of life. The observed differences are of utmost importance to patients and their families and palliation of osseous manifestations is a priority, given their relatively long lifespan. We define NGPS as a chronic progeria because of its slow clinical course and relatively long survival, despite its early onset. Understanding the differences between progeria syndromes might contribute to the development of treatment strategies for common skeletal conditions, as well as aging itself.